BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 7874873)

  • 41. Progress in the control of oral anticoagulation.
    Loeliger EA
    Thromb Diath Haemorrh; 1972 Aug; 28(1):109-19. PubMed ID: 5074987
    [No Abstract]   [Full Text] [Related]  

  • 42. Are capillary whole blood coagulation monitors suitable for the control of oral anticoagulant treatment by the international normalized ratio?
    Tripodi A; Arbini AA; Chantarangkul V; Bettega D; Mannucci PM
    Thromb Haemost; 1993 Dec; 70(6):921-4. PubMed ID: 8165612
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Laboratory testing of anticoagulants: the present and the future.
    Favaloro EJ; Lippi G; Koutts J
    Pathology; 2011 Dec; 43(7):682-92. PubMed ID: 22081129
    [TBL] [Abstract][Full Text] [Related]  

  • 44. International sensitivity index calibration of the near-patient testing prothrombin time monitor, ProTime.
    Tripodi A; Chantarangkul V; Bressi C; Mannucci PM
    Am J Clin Pathol; 2003 Feb; 119(2):241-5. PubMed ID: 12579994
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Laboratory control over warfarin therapy in patients with acute coronary syndrome].
    Baluda MV; Lopukhina MV; Fomina VM; Lopukhin VO
    Ter Arkh; 2005; 77(10):68-71. PubMed ID: 16320690
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of a chromogenic factor X assay with international normalized ratio for monitoring oral anticoagulation therapy.
    McGlasson DL; Romick BG; Rubal BJ
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):513-7. PubMed ID: 18685434
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A multicenter study on amidolytic factor X evaluation in oral anticoagulant therapy.
    Berthier AM; Pommereuil M; Scarabin PY; Conard J
    Thromb Haemost; 1985 Jun; 53(3):433-6. PubMed ID: 4049314
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Home prothrombin time monitoring: a literature analysis.
    Yang DT; Robetorye RS; Rodgers GM
    Am J Hematol; 2004 Oct; 77(2):177-86. PubMed ID: 15389909
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Laboratory monitoring of oral anticoagulant therapy.
    Ginsberg JS; Hirsh J
    Hematol Pathol; 1989; 3(4):147-51. PubMed ID: 2697715
    [No Abstract]   [Full Text] [Related]  

  • 50. [External quality control and standardization of prothrombin time determination for the monitoring of oral anticoagulant treatment in the Netherlands].
    van Duuk-Wierda CA; Loeliger EA; Roos J
    Ned Tijdschr Geneeskd; 1980 Jan; 124(4):103-7. PubMed ID: 7374832
    [No Abstract]   [Full Text] [Related]  

  • 51. Establishing an oral anticoagulant monitoring service in a multiethnic developing country.
    Casimire T; Carter R; Peters S; Tweedle J; Charles KS
    Int J Lab Hematol; 2008 Dec; 30(6):531-5. PubMed ID: 18983306
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comparison of INRs determined with a whole blood prothrombin time device and two international reference preparations for thromboplastin.
    van den Besselaar AM
    Thromb Haemost; 2000 Sep; 84(3):410-2. PubMed ID: 11019963
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Are laboratories following published recommendations for lupus anticoagulant testing? An international evaluation of practices.
    Moffat KA; Ledford-Kraemer MR; Plumhoff EA; McKay H; Nichols WL; Meijer P; Hayward CP
    Thromb Haemost; 2009 Jan; 101(1):178-84. PubMed ID: 19132206
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Management of oral anticoagulant treatment in patients with venous thromboembolism.
    Pengo V
    Semin Thromb Hemost; 2006 Nov; 32(8):781-6. PubMed ID: 17171590
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dosage and control of oral anticoagulants: an international collaborative survey.
    Poller L; Taberner DA
    Br J Haematol; 1982 Jul; 51(3):479-85. PubMed ID: 7104231
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Prothrombin time and its standardization].
    Kagawa K
    Rinsho Byori; 2002 Aug; 50(8):779-85. PubMed ID: 12373814
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A new plastic collection tube made of polyethylene terephtalate is suitable for monitoring traditional anticoagulant therapy (oral anticoagulant, unfractionated heparin, and low molecular weight heparin).
    Toulon P; Ajzenberg N; Smahi M; Guillin MC
    Thromb Res; 2007; 119(2):135-43. PubMed ID: 16426667
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Comparative multicenter study of a rabbit high-sensitivity thromboplastin and a recombinant thromboplastin with synthetic phospholipids].
    Martínez-Brotóns F; Borrell M; Fontcuberta J; Batlle J; López F; Páramo JA; Ribera C; Rocha E; Vicente V; Zuazu I
    Sangre (Barc); 1994 Aug; 39(4):245-51. PubMed ID: 7985052
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thromboplastin and oral anticoagulant control.
    Lewis SM
    Br J Haematol; 1987 May; 66(1):1-4. PubMed ID: 3593643
    [No Abstract]   [Full Text] [Related]  

  • 60. A comparison of point-of-care instruments designed for monitoring oral anticoagulation with standard laboratory methods.
    Gosselin R; Owings JT; White RH; Hutchinson R; Branch J; Mahackian K; Johnston M; Larkin EC
    Thromb Haemost; 2000 May; 83(5):698-703. PubMed ID: 10823265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.